Drug discovery
Coverage of Drug discovery in the Nexus archive.
- Trump administration says 15 agencies will get $5bn in ‘AI for science’ effort
The Trump administration announced $5 billion in funding for 15 agencies to advance scientific research using AI. The initiative aims to address chronic diseases, accelerate drug discovery, and develop durable building materials, with scientists gaining access to Department of Energy supercomputers and datasets.
- Bristol Myers Squibb is deploying NVIDIA's most powerful AI computing system to speed drug discovery
Bristol Myers Squibb is implementing NVIDIA's Vera Rubin systems to accelerate drug discovery. The systems are described as the most powerful AI computing infrastructure in life sciences.
- Eli Lilly deploys weight-loss cash on ‘App Store’ for scientists
Eli Lilly, the maker of Mounjaro, is using funds from its weight-loss drug to develop an 'App Store' for scientists. The company is collaborating with small biotechs to leverage AI as a tool for drug discovery.
- China unveils world’s first superfast quantum memory, paving way for practical computing
Chinese scientists have developed the world's first superfast quantum memory, addressing a critical data-reading bottleneck. This advancement could enable quantum computers to tackle big-data challenges such as drug discovery and detecting fraudulent financial activities.
- From decades to years - AI could speed search for brain drugs hiding in plain sight
Researchers are using AI to accelerate the discovery of existing drugs for brain conditions like MND, aiming to reduce development timelines from decades to years and identify affordable treatments.
- From decades to years - AI could speed search for brain drugs hiding in plain sight
Researchers are using AI to accelerate the search for existing drugs that can treat brain conditions like MND, potentially reducing development timelines from decades to years. The goal is to identify affordable and effective therapies already in use but not yet applied to these neurological disorders.
- AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.
10x Science, a startup focused on pharmaceutical research, has secured a $4.8 million seed round to help scientists analyze complex molecules generated by AI-driven drug discovery.
- OpenAI's New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can't Use It
OpenAI has developed GPT-Rosalind, a domain-specific AI model for drug discovery and life sciences. The model is not accessible to the general public.
- Mix-and-match synthesis of 3D small molecules
A new chemistry method enabling modular synthesis of 3D organic molecules through carbon-carbon bond formation was published in Nature. This advancement could significantly impact drug discovery and materials design.